Back to top

Procept BioRobotics assumed with Neutral from Buy at UBS

UBS analyst Patrick Wood downgraded Procept BioRobotics (PRCT) to Neutral from Buy with a price target of $20, down from $30, after assuming covera...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

PROCEPT BioRobotics Corporation (PRCT)